Please assess the completion status of the following clinical trial:

Trial Title: Feasibility in the Prophylaxis of Radiation Dermatitis Severity

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 18years~* Undergoing external beam radiotherapy for head/neck cancer at Mayo Clinic Rochester campus.~Note: patients undergoing concurrent chemotherapy are eligible.~* Able to provide informed written consent~* Willing to consent for photography of radiation field~* Receiving a dose ≥ 45 Gy and 20 fractions to both the area being treated and the area being used for comparison~Exclusion Criteria:~* Patients with active rash, pre-existing dermatitis, lupus, tattoos, scleroderma or other conditions within the treatment area that may make skin assessment for the study difficult per treating physician discretion.~* Patients with known allergic and other systemic skin diseases even if not directly affecting irradiated fields.~* Any medical condition that in the opinion of the investigator should exclude him/her from participating in the study.~* Enrolled in an investigational study where product was applied to the proposed study site within 30 days of the screening visit~* The skin area affected by radiation requires treatment with a concomitant medication or product (if applicable)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group 1- StrataXRT (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).